Community Care Intervention for COVID-19 Vaccination
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but it's best to confirm with the trial organizers.
What data supports the effectiveness of the treatment CHW-VB, Community Health Worker Intervention, CHW Intervention, CHW-VB for COVID-19 vaccination?
Research shows that community health workers (CHWs) can help increase access to vaccines in underserved areas and improve health outcomes by providing community-based care. They have been effective in reducing hospitalizations and improving health knowledge, which suggests they could be beneficial in increasing COVID-19 vaccination rates.12345
Is the Community Care Intervention for COVID-19 Vaccination safe for humans?
The research does not provide specific safety data for the Community Care Intervention or related terms like CHW-VB, but community health workers (CHWs) have been involved in health promotion and vaccine education, which suggests a focus on safe practices. However, no direct safety concerns are mentioned in the available studies.25678
How does the Community Care Intervention for COVID-19 Vaccination differ from other treatments?
The Community Care Intervention for COVID-19 Vaccination is unique because it involves community health workers (CHWs) who are trained to administer vaccines and engage with under-reached communities, helping to overcome barriers like mistrust and access issues. This approach leverages the trust and accessibility of CHWs to improve vaccination rates, especially in vulnerable populations.29101112
What is the purpose of this trial?
The purpose of this study is to find out if a community health workers (CHW) intervention conducted in Federally Qualified Health Centers (FQHCs) can increase the number of adults with chronic illnesses who are up-to-date with their COVID-19 and influenza vaccines.
Research Team
Marielena Lara, MD, MPH
Principal Investigator
RAND
Lisa Meredith, PhD
Principal Investigator
RAND
Jonathan Tobin, PhD
Principal Investigator
Clinical Directors Network
Andrea Cassells, MPH
Principal Investigator
Clinical Directors Network
Eligibility Criteria
This trial is for adults over 18 who speak English or Spanish and can complete an assessment without confusion. It's not for those unwilling to consent, acutely sick individuals, or people at high risk of suicide.Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants in the CHW group receive up to 3 psychoeducational sessions to address barriers to COVID-19 and influenza vaccination.
Follow-up
Participants are monitored for vaccine acceptance and uptake at 3 months.
Treatment Details
Interventions
- CHW-VB
Find a Clinic Near You
Who Is Running the Clinical Trial?
RAND
Lead Sponsor
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
Clinical Directors Network
Collaborator